Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CAH · against 57 other Healthcare companies of similar size
Ranked #31 of 58 · scores higher than 47% of peers
Bars: peers in each 10-point band of the valuation score15 peers with a valuation score of 50–59, including CAH · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | CAH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 55 reported | 2.9% | 3.0% | 44% | 30% | |
| EBITDA yieldHigher is better · 59 reported | 6.6% | 6.1% | 60% | 50% | |
| Free cash flow yieldHigher is better · 42 reported | 7.7% | 4.1% | 90% | 20% | |
| Book yieldHigher is better · 54 reported | -4.9% | 21.1% | 2% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 108.6B USD | 88 | 66 | |
| 4 | 97.5B USD | 87 | 67 | |
| 5 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 27 | 36.8B USD | 61 | 46 | |
| 27 | 100.2B USD | 61 | 68 | |
| 29 | 43.2B USD | 60 | 45 | |
| 30 | 35.0B USD | 59 | 52 | |
| 31 | 58.6B USD | 58 | 52 | |
| 32 | 8.24T JPY (≈$56.0B) | 57 | 75 | |
| 32 | 54.0B USD | 57 | 47 | |
| 32 | 31.3B USD | 57 | 63 | |
| 35 | 4.25T INR (≈$51.0B) | 56 | 70 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score